Sort
48,018 grants matching “immunotherapy”
SMALL ANIMAL MULTI-MODALITY IMAGING CENTER (SAMMIC)
$562,734University Of Pennsylvania · R24 · FY2002 · CA
Precision Targeting of CD1-Restricted iNKT Cells for Cancer Immunotherapy
$562,714Steven A Porcelli · Albert Einstein College Of Medicine · R01 · FY2023 · AI
Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer
$562,656Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2022 · CA
Western Regional Community Clinical Oncology Program
$562,644Banner Good Samaritan Medical Center · U10 · FY2004 · CA
Research Program in Immunology
$562,611Boston University Medical Campus · T32 · FY2003 · AI
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$562,597Jin-Ming Yang · University Of Kentucky · R01 · FY2020 · CA
Real time scattered x-ray imaging for tumor motion tracking in radiotherapy.
$562,587Xun Jia · Johns Hopkins University · R01 · FY2025 · CA
Regulatory T Cell Function in Ovarian Cancer
$562,552Kirsten B Moysich · Roswell Park Cancer Institute Corp · R01 · FY2009 · CA
Hexokinase 2 and cancer therapy
$562,533Nissim Hay · University Of Illinois At Chicago · R01 · FY2022 · CA
Hexokinase 2 and cancer therapy
$562,533Nissim Hay · University Of Illinois At Chicago · R01 · FY2023 · CA
Transformative personalized vascular disrupting cancer immunotherapy
$562,439George Coukos · University Of Pennsylvania · R01 · FY2013 · CA
Znf740 in the regulation of CD8+T cell exhaustion
$562,412Venuprasad K Poojary · Ut Southwestern Medical Center · R01 · FY2025 · CA
ADVANCING IMMUNOTHERAPY IN BREAST CANCER LOCAL REPROGRAMMING OF TUMOR-ASSOCIATED MACROPHAGES WITH NOVEL BIOMATERIALS FOR SYSTEMIC ADAPTIVE ANTICANCE
$562,385Vanderbilt University · · FY2019 · Defense Health Agency
Molecular Basis of CD1D and Natural Killer T Cell Function
$562,298Sebastian Joyce · Vanderbilt University Medical Center · R01 · FY2019 · AI
Project 1
$562,281David J Odde · University Of Minnesota · P01 · FY2025 · CA
Molecular Control of Plasmacytoid Dendritic Cell Development and Function
$562,242Boris Reizis · New York University School Of Medicine · R37 · FY2021 · AI
Elucidation of Human Natural Killer Cell Development
$562,208Aharon G Freud · Ohio State University · R01 · FY2025 · CA
Molecular and immunological heterogeneity of Small Cell Lung Cancer (SCLC) and its impact on relapse and therapeutic response
$561,956Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
Elucidating Mechanism of Immune Evasion in Head and Neck Cancers
$561,945Jing Hong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · DE
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$561,929Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Circadian Clock Disruption and Colorectal Cancer
$561,917Selma Masri · University Of California-Irvine · R01 · FY2025 · CA
Restoring the Immunogenicity of Head and Neck Cancer
$561,890Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2023 · DE
Nucleus Accumbens-Associated Protein-1 in Melanoma Immunotherapy
$561,881Jin-Ming Yang · University Of Kentucky · R01 · FY2021 · CA
Next-generation genetic engineering of the pan-leukocyte antigen CD45 to facilitate CAR-T cell therapy against hematologic malignancies
$561,800Saar Gill · University Of Pennsylvania · P01 · FY2024 · CA
Targeting Alloreactivity for Leukemia Eradication
$561,787Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA